Runnymede Capital Advisors, Inc. Embecta Corp. Transaction History
Runnymede Capital Advisors, Inc.
- $114 Billion
- Q4 2024
A detailed history of Runnymede Capital Advisors, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Runnymede Capital Advisors, Inc. holds 4 shares of EMBC stock, worth $70. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4Holding current value
$70% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EMBC
# of Institutions
401Shares Held
51.9MCall Options Held
162KPut Options Held
61K-
Black Rock Inc. New York, NY9.19MShares$161 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.03MShares$123 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO3.26MShares$57.1 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$56.8 Million0.95% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.73MShares$47.8 Million0.72% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $1.01B
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...